1. A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01). Issue 12 (24th April 2020) Authors: Balana, Carmen; Vaz, Maria Angeles; Manuel Sepúlveda, Juan; Mesia, Carlos; del Barco, Sonia; Pineda, Estela; Muñoz-Langa, Jose; Estival, Anna; de las Peñas, Ramón; Fuster, Jose; Gironés, Regina; Navarro, Luis Miguel; Gil-Gil, Miguel; Alonso, Miriam; Herrero, Ana; Peralta, Sergio; Olier, Clara; Pe... Journal: Neuro-oncology Issue: Volume 22:Issue 12(2020) Page Start: 1851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Timely Oral Option: Single‐Agent Vinorelbine in Desmoid Tumors. (2nd October 2020) Authors: Gennatas, Spyridon; Chamberlain, Florence; Smrke, Alannah; Stewart, James; Hayes, Andrew; Roden, Lorna; Messiou, Christina; Kowa, Jie‐Ying; Estival, Anna; Chauhan, Dharmisha; Thway, Khin; Fisher, Cyril; van der Graaf, Winette T. A.; Jones, Robin L.; Benson, Charlotte Journal: Oncologist Issue: Volume 25:Number 12(2020) Page Start: e2013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib. (20th August 2018) Authors: Serrano, César; García‐del‐Muro, Xavier; Valverde, Claudia; Sebio, Ana; Durán, José; Manzano, Aránzazu; Pajares, Isabel; Hindi, Nadia; Landolfi, Stefania; Jiménez, Laura; Rubió‐Casadevall, Jordi; Estival, Anna; Lavernia, Javier; Safont, María José; Pericay, Carles; Díaz‐Beveridge, Roberto; Martín... Journal: Oncologist Issue: Volume 24:Number 5(2019) Page Start: 680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Issue 11 (4th March 2020) Authors: D'Ambrosio, Lorenzo; Touati, Nathan; Blay, Jean‐Yves; Grignani, Giovanni; Flippot, Ronan; Czarnecka, Anna M.; Piperno‐Neumann, Sophie; Martin‐Broto, Javier; Sanfilippo, Roberta; Katz, Daniela; Duffaud, Florence; Vincenzi, Bruno; Stark, Daniel P.; Mazzeo, Filomena; Tuchscherer, Armin; Chevreau, Ch... Journal: Cancer Issue: Volume 126:Issue 11(2020) Page Start: 2637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pseudoprogression as an adverse event of glioblastoma therapy. (3rd November 2017) Authors: Balaña, Carmen; Capellades, Jaume; Pineda, Estela; Estival, Anna; Puig, Josep; Domenech, Sira; Verger, Eugenia; Pujol, Teresa; Martinez‐García, Maria; Oleaga, Laura; Velarde, JoseMaria; Mesia, Carlos; Fuentes, Rafael; Marruecos, Jordi; Del Barco, Sonia; Villà, Salvador; Carrato, Cristina; Gallego... Journal: Cancer medicine Issue: Volume 6:Number 12(2018:Dec.) Page Start: 2858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA". (July 2021) Authors: Schöffski, Patrick; Toulmonde, Maud; Estival, Anna; Marquina, Gloria; Dudzisz-Śledź, Monika; Brahmi, Mehdi; Steeghs, Neeltje; Karavasilis, Vasilios; de Haan, Jacco; Wozniak, Agnieszka; Cousin, Sophie; Domènech, Marta; Bovée, Judith V.M.G.; Charon-Barra, Céline; Marreaud, Sandrine; Litière, Saskia... Journal: European journal of cancer Issue: Volume 152(2021) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗